Mad Money w/ Jim Cramer Mad Money w/ Jim Cramer 11/10/25
6 snips
Nov 11, 2025 Bob Bradway, Chairman and CEO of Amgen, shares groundbreaking phase three results for Repatha, showing promise in heart-attack prevention, and introduces Meritide, a potential game-changer for obesity and diabetes. Meanwhile, Dr. Alan Baratz, CEO of D-Wave Quantum, discusses the rapid commercial adoption of their quantum systems, highlighting major clients like Japan Tobacco. Baratz also delves into the technical innovations behind D-Wave's offerings and the competitive landscape in quantum computing.
AI Snips
Chapters
Books
Transcript
Episode notes
Market Leadership Recovers After Macro Shocks
- Market sentiment can reverse quickly when political or macro risks fade, restoring leadership sectors like AI and data centers.
- Trusting market leadership after short-term shocks can avoid missing major rallies in dominant themes.
NVIDIA Millionaires At A Signing
- Jim Cramer described meeting NVIDIA employees who became millionaires and crying at a signing event.
- He used the story to illustrate how individual investors made fortunes in winners like NVIDIA.
Prefer Best-In-Class Subscription Stocks
- Consider subscription businesses like Netflix for stable, repeatable revenue and resilience.
- Buy into best-in-class subscription models rather than chasing one-off fads.
